June « 2017 « Science and Enterprise

Commercial-Scale Flu Vaccine Produced in Cell Cultures

By Alan, on June 21st, 2017%

A vaccine developer says it produced large quantities of a current influenza vaccine for distribution to clinics and hospitals, grown in animal cell cultures rather than eggs. . . . → Read More: Commercial-Scale Flu Vaccine Produced in Cell Cultures

Organ Chips to be Studied on Space Station

By Alan, on June 21st, 2017%

A range of biological functions will be assessed with model organs on plastic chips in a series of experiments on the International Space Station. . . . → Read More: Organ Chips to be Studied on Space Station

FDA Approves Skin Infection Drug

By Alan, on June 20th, 2017%

The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics. . . . → Read More: FDA Approves Skin Infection Drug

Engineered Algae Doubles Bio-Oil Content

By Alan, on June 19th, 2017%

An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow. . . . → Read More: Engineered Algae Doubles Bio-Oil Content

Exosuit Prototype Unveiled for Stroke Survivors

By Alan, on June 19th, 2017%

An assistive device with sensors and motors designed to help people with stroke and other muscle disorders walk more normally was demonstrated on 16 June. . . . → Read More: Exosuit Prototype Unveiled for Stroke Survivors

FDA Developing Digital Device Certification Process

By Alan, on June 16th, 2017%

The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market. . . . → Read More: FDA Developing Digital Device Certification Process

Cancer Drug Produced in Small Continuous-Flow Batches

By Alan, on June 16th, 2017%

A team from drug maker Eli Lilly & Company devised techniques for producing an experimental cancer drug in small quantities but with safe, economical methods used in continuous flow manufacturing. . . . → Read More: Cancer Drug Produced in Small Continuous-Flow Batches

Coalition to Make 10,000 Open-Access Synthetic Genes

By Alan, on June 15th, 2017%

A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes

$300M Fund to Back European Life Science Companies

By Alan, on June 15th, 2017%

A new investment fund plans to invest $300 million in European life science and biotechnology companies in the later stages of their product development. . . . → Read More: $300M Fund to Back European Life Science Companies

First Agricultural Crispr Products Expected by 2020

By Alan, on June 14th, 2017%

While the genome editing technique known as Crispr is generating discussion in the health field, its first commercial applications are likely to be in agriculture. . . . → Read More: First Agricultural Crispr Products Expected by 2020

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise